NCT06626360 Screening for Malnutrition in Obese Patients
| NCT ID | NCT06626360 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HAN University of Applied Sciences |
| Condition | Overweight and Obese Adults |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-10-02 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-10-02 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
More than half of the Dutch population is overweight or obese, which is associated with an increased risk of COVID-19 and worse outcomes during a COVID-19 infection. In addition, malnutrition and loss of muscle mass are often reported with COVID-19, as well as with cancer and other diseases. Malnutrition and overweight or obesity can coexist, even within the same individual. It is still unclear which mechanisms contribute to the worse outcomes of COVID-19 and other diseases in case of overweight, malnutrition, and a combination of both. The aim of this study is to identify which parameters are associated with worse disease outcomes through literature research and database research (COVID-19 and cancer, more than 150.000 participants). In addition, a clinical study will be conducted aiming to develop a simple screening tool for the recognition of the coexistence of malnutrition and overweight or obesity in clinical practice.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Overweight (BMI of 25 kg/m² or higher) Exclusion Criteria: * Physically or mentally unable to participate. * Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician. * Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help. * Patient resides in a nursing or care home.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06626360 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Overweight and Obese Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06626360 currently recruiting?
Yes, NCT06626360 is actively recruiting participants. Contact the research team at marian.devanderschueren@han.nl for enrollment information.
Where is the NCT06626360 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands, Ede, Netherlands, Rotterdam, Netherlands.
Who is sponsoring the NCT06626360 clinical trial?
NCT06626360 is sponsored by HAN University of Applied Sciences. The trial plans to enroll 2,000 participants.